Events

Annual POLIS conference 2023
NOV
Wed
29
NOV
Thu
30

This was 2 years ago

Location

Leuven

Brabanthal
Programmes
Climate, Energy, Mobility Missions

Attachments

There is 1 attachment connected to this article.

Attachments are only accessible for people with an account on the NCP Flanders website.

Sign in (if you already have an account) or sign up.

The annual POLIS conference 2023 will take place in Leuven. Participants include high-level decision makers, mobility experts and practitioners, ... showcasing their latest transport projects, discussing the future of mobility and innovative solutions in the transport sector.

This year's edition will have 32 sessions and 2 plenaries. Each session is related to one of five thematic areas:

  • Environment & Health;
  • Traffic Efficiency;
  • Access;
  • Road Safety & Security;
  • Governance & Integration.

You can find more information on the main website. The current programme is attached to this message.

The registration deadline for this event is 14 November 2023.

 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.